Morrell N W, Grieshaber S S, Danilov S M, Majack R A, Stenmark K R
Department of Pediatrics, University of Colorado Health Sciences Center, Denver 80262, USA.
Am J Respir Cell Mol Biol. 1996 Jun;14(6):526-37. doi: 10.1165/ajrcmb.14.6.8652181.
Factors that influence the development of the normal pulmonary vasculature are poorly understood. Since increased local production of angiotensin II (AII) by angiotensin converting enzyme (ACE) has been implicated in the medial hypertrophy of systemic and pulmonary hypertension, we questioned whether ACE and angiotensin receptor expression may influence the muscularization of the normal pulmonary vasculature during development. The approach employed measurement of lung ACE activity, assessment of local ACE expression by immunohistochemistry, and angiotensin type 1 receptor (AT1) expression by in situ hybridization in rat lungs ranging from 15 days of intrauterine life (term = 21 d) to adulthood. The temporal and spatial pattern of ACE expression was compared with that of the endothelial marker, von Willebrand factor (vWF), and the smooth muscle cell markers, alpha smooth muscle actin and smooth muscle myosin. ACE activity was first detected in lung homogenates on day 17 of gestation (1 +/- 0.2 mU/mg) and increased progressively to term (27.7 +/- 3.2 mU/mg). However, the greatest increase in lung ACE activity to adult levels (379 +/- 25.2 mU/mg) occurred between 2 and 4 wk of postnatal life. Immunohistochemistry demonstrated vWF expression by vascular endothelium throughout the lung as early as day 15 of gestation. In contrast, ACE expression was observed in the endothelium of only hilar pulmonary arteries on day 15 of gestation, and thereafter was noted to be expressed in endothelial cells of progressively more distal arteries, such that by term, endothelial cells of all muscularized arteries expressed ACE. Alveolar capillary ACE expression was not detected until day 20 of gestation, and increased dramatically after birth. Smooth muscle actin expression in lung arteries closely paralleled the expression of endothelial ACE. AT1 receptor mRNA was first expressed in the peripheral lung on day 17 of gestation by non-epithelial undifferentiated mesenchyme. In contrast, AT1 mRNA signal was much reduced in differentiated smooth muscle. We speculate that ACE expression in the fetal lung circulation may influence the muscularization of fetal pulmonary arteries by the interaction of locally produced angiotensin II with the AT1 receptor.
影响正常肺血管系统发育的因素目前尚不清楚。由于血管紧张素转换酶(ACE)使局部血管紧张素II(AII)生成增加与体循环和肺循环高血压的中膜肥厚有关,我们质疑ACE和血管紧张素受体表达是否会在发育过程中影响正常肺血管系统的肌化。该研究方法包括测量大鼠肺ACE活性、通过免疫组织化学评估局部ACE表达以及通过原位杂交评估血管紧张素1型受体(AT1)表达,大鼠肺取材范围从子宫内生活15天(足月为21天)至成年期。将ACE表达的时空模式与内皮标志物血管性血友病因子(vWF)以及平滑肌细胞标志物α平滑肌肌动蛋白和平滑肌肌球蛋白的时空模式进行比较。ACE活性在妊娠第17天首次在肺匀浆中检测到(1±0.2 mU/mg),并逐渐增加至足月(27.7±3.2 mU/mg)。然而肺ACE活性增加至成年水平(379±25.2 mU/mg)幅度最大的时候是在出生后2至4周。免疫组织化学显示早在妊娠第15天整个肺的血管内皮就有vWF表达。相比之下,妊娠第15天仅在肺门肺动脉内皮中观察到ACE表达,此后逐渐在更远端动脉的内皮细胞中表达,到足月时,所有肌化动脉的内皮细胞均表达ACE。直到妊娠第20天才检测到肺泡毛细血管ACE表达,出生后显著增加。肺血管中平滑肌肌动蛋白的表达与内皮ACE的表达密切平行。AT1受体mRNA在妊娠第17天由非上皮未分化间充质首先在外周肺中表达。相比之下,在分化的平滑肌中AT1 mRNA信号则大大减少。我们推测胎儿肺循环中的ACE表达可能通过局部产生的血管紧张素II与AT1受体的相互作用来影响胎儿肺动脉的肌化。